文献速递冠心病外科

冠状动脉旁路移植术后继发性手术部位感染:多机构前瞻性队列研究

Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-12-06

该多机构前瞻性队列研究纳入2010年2月至10月间接受大隐静脉桥血管冠状动脉旁路移植术的2174例成人患者,其中65例(3.0%)发生继发性手术部位感染,中位诊断时间16天,86%在出院后诊断。校正后开放大隐静脉获取方式(校正HR 2.12,95%CI 1.28-3.48)、体重指数升高(校正HR 1.08,95%CI 1.04-1.12)和输注浓缩红细胞(校正HR 1.13,95%CI 1.05-1.22)与继发性手术部位感染风险增加相关;抗生素类型、抗生素疗程和术后高血糖与风险无关。

要点

  • 2174例冠状动脉旁路移植术患者中65例(3.0%)发生继发性手术部位感染,86%在出院后诊断。
  • 开放大隐静脉获取方式与继发性手术部位感染风险增加相关(校正HR 2.12,95%CI 1.28-3.48)。
  • 体重指数升高和输注浓缩红细胞与继发性手术部位感染风险增加相关,抗生素类型、疗程及术后高血糖与风险无关。

核心结论

  • 冠状动脉旁路移植术后继发性手术部位感染仍是重要的致病原因,常发生在出院后,与开放大隐静脉获取、较大体重和输血相关,此类患者住院时间更长且再入院更频繁。

研究设计与样本

  • 多机构前瞻性队列研究,于2010年2月至10月前瞻性收集接受大隐静脉桥血管冠状动脉旁路移植术的知情同意成人患者数据,将术后65天内发生腿部或腹股沟深部或浅部继发性手术部位感染者与未发生者进行比较。

主要发现

  • 2174例患者中65例(3.0%)发生继发性手术部位感染,中位诊断时间16天(四分位距11-29),86%在出院后诊断,革兰阳性菌最常见。
  • 继发性手术部位感染患者再入院更常见(34% vs 17%,P < .01)。
  • 校正后开放大隐静脉获取方式与继发性手术部位感染风险增加相关(校正HR 2.12,95%CI 1.28-3.48)。
  • 体重指数升高(校正HR 1.08,95%CI 1.04-1.12)和输注浓缩红细胞(校正HR 1.13,95%CI 1.05-1.22)与继发性手术部位感染风险增加相关。
  • 抗生素类型、抗生素疗程和术后高血糖与继发性手术部位感染风险无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze patient risk factors and processes of care associated with secondary surgical-site infection (SSI) after coronary artery bypass grafting (CABG). METHODS: Data were collected prospectively between February and October 2010 for consenting adult patients undergoing CABG with saphenous vein graft (SVG) conduits. Patients who developed a deep or superficial SSI of the leg or groin within 65 days of CABG were compared with those who did not develop a secondary SSI. RESULTS: Among 2174 patients identified, 65 (3.0%) developed a secondary SSI. Median time to diagnosis was 16 days (interquartile range 11-29) with the majority (86%) diagnosed after discharge. Gram-positive bacteria were most common. Readmission was more common in patients with a secondary SSI (34% vs 17%, P < .01). After adjustment, an open SVG harvest approach was associated with an increased risk of secondary SSI (adjusted hazard ratio [HR], 2.12; 95% confidence interval [CI], 1.28-3.48). Increased body mass index (adjusted HR, 1.08, 95% CI, 1.04-1.12) and packed red blood cell transfusions (adjusted HR, 1.13; 95% CI, 1.05-1.22) were associated with a greater risk of secondary SSI. Antibiotic type, antibiotic duration, and postoperative hyperglycemia were not associated with risk of secondary SSI. CONCLUSIONS: Secondary SSI after CABG continues to be an important source of morbidity. This serious complication often occurs after discharge and is associated with open SVG harvesting, larger body mass, and blood transfusions. Patients with a secondary SSI have longer lengths of stay and are readmitted more frequently.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gulack BC, Kirkwood KA, Shi W, et al. Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study. J Thorac Cardiovasc Surg. 2017. PMID: 29221750. doi:10.1016/j.jtcvs.2017.10.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。